王晞星教授运用当归贝母苦参丸加减治疗肾癌经验

Professor Wang Xixing′s Clinical Experience in Treating Renal Cancer with Angelica Fritillaria Kushen Pill Addition and Subtraction

肾癌是泌尿系常见恶性肿瘤,约占恶性肿瘤的2%~3%,临床上肾透明细胞癌最为常见。肾癌患者临床上对放化疗不敏感,常规以手术治疗为主,免疫治疗、靶向治疗或者多手段联合治疗为辅,但对于不接受上述治疗手段或者不耐受其毒副作用的患者而言,中医药常作为首选的治疗手段。王晞星教授从事中医临床40余载,通过联系前人经验,结合临床辨病辨证,灵活的把妇科名方当归贝母苦参丸加减应用于肾癌患者的临床治疗中,见解独特,临床疗效显著,积累了丰富的临床经验,值得推广及学习。

Renal Cancer is a common malignant tumor of the urinary system,accounting for 2%~3%of malignant tumors.Clinically,clear renal cell carcinoma is the most common.Renal cancer patients are not sensitive to radiotherapy and chemotherapy in clinical practice.They are usually treated with surgery,supplemented by immunotherapy,targeted therapy or multiple treatments,but for patients who do not receive the above treatment or are intolerant of their side effects.Chinese medicine is often used as the the preferred treatment.Professor Wang Zhaoxing has engaged in dinical work of traditional chinese medicine for more than 40 years.Professor Wang Xixing contacted the experience of the predecessors,combined with clinical syndrome differentiation,flexible application of gynecological prescription of Danggui Fritillaria Kushen Pill in the treatment of patients with renal cancer,unique insights,clinical efficacy,The wealth of valuable clinical experience is worthy of clinical promotion and learning.The authors now summarize the clinical experience of the clinical treatment of renal cancer.